Ireland
--:--IST
Recruiting Not applicable

Non-Invasive Ventilation Versus High-flow Nasal Oxygen in Intensive Care Units

NCT05686850 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2023-02-02
Last updated
2026-05-26

Condition(s) studied

Post Extubation Respiratory Failure

Investigational drug(s) / intervention(s)

High-Flow OxygenNon invasive ventilation

High-Flow Oxygen: Humidified and heated oxygen with a gas flow at least 50 L/min through nasal cannula

Non invasive ventilation: NIV will be carried out in pressure-support mode with a minimal pressure-support level of 5 cmH2O targeting a tidal volume around 6 to 8 mL/kg of predicted bodyweight, a positive end-expiratory pressure (PEEP) level at least 8 cm H2O, and FiO2 adjusted to obtain adequate oxygenation

Study summary

In intensive care units (ICUs), around 20% of patients experience respiratory failure after planned extubation. Nearly 40-50% of them eventually require reintubation with subsequently high mortality rates reaching 30-40%. NIV used as rescue therapy to treat post-extubation respiratory failure could increase the risk of death. However, NIV may avoid reintubation in a number of cases, and recent large-scale clinical trials on extubation have shown that around 40 to 50% of patients with post-extubation respiratory failure are actually treated with NIV. Whereas high-flow nasal oxygen has never been specifically studied for management of post-extubation respiratory failure, this respiratory support could also in this setting constitute an alternative to standard oxygen or NIV. Given the best noninvasive respiratory support strategy in patients with post-extubation respiratory failure remains unknown, we have decided to assess whether NIV alternating with high-flow nasal oxygen as compared to high-flow nasal oxygen alone may decrease mortality of patients in ICUs with post-extubation respiratory failure.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Duration of invasive mechanical ventilation of more than 24h in the ICU before extubation. * Post-extubation respiratory failure occurring within the first 7 days after extubation (see criteria below). As in several previous studies, post-extubation respiratory failure will be defined by the presence of the 2 following criteria combining a clinical criterion and a blood gas criterion: * Clinical criterion persisting for at least 30 minutes: a respiratory rate exceeding 25 breaths per minute or clinical signs of respiratory distress with increased accessory muscle activity. * Blood gas criterion: Hypoxemia defined as PaO2/FiO2 ratio below 150 mm Hg or respiratory acidosis defined as pH below 7.35 units and PaCO2 above 45 mm Hg. For patients under standard oxygen, FiO2 will calculated according to the following formula: FiO2 = 0.21 + 0.03 x (oxygen flow L/min). * Informed consent from the relatives or the patient himself, or emergency inclusion procedure in case of inability of patient or proxy to give consent. Exclusion Criteria: * NIV at home * ICU admission for peripheral neuromuscular disease type Guillain-Barré syndrome or myasthenia gravis. * Upper airway obstruction as main reason for post-extubation respiratory failure * Urgent need for reintubation (respiratory or cardiac arrest, respiratory pauses with loss of consciousness or gasping for air, or severe hypoxemia defined as SpO2 lower than 90% despite maximal oxygen support) * Altered consciousness (Glasgow coma scale \< 12) * Unplanned extubation (accidental or self-extubation) * Do-not-reintubate order at time of respiratory failure * Patient previously included in the study * People under protection (minors, persons deprived of liberty by a judicial or administrative decision, adults under law protection) * Patient not affiliated to health care system.

Primary outcome measure(s)

  • Mortality at 28 days after post-extubation respiratory failure — Day 28
    Death between post-extubation respiratory failure and 28 days after post-extubation respiratory failure

Trial sites (47)

FacilityCityRegionStatus
Erasme Hospital Brussels Belgium Recruiting
Angers University Hospital Angers France Recruiting
Victor Dupouy Hospital Argenteuil France Recruiting
Henri Mondor Hospital Aurillac France Recruiting
Henri Duffaut Hospital Avignon France Recruiting
Nord-Franche-Comté Hospital Belfort France Recruiting
Bordeaux University Hospital Bordeaux France Withdrawn
Fleyriat Hospital Bourg-en-Bresse France Recruiting
Brest University Hospital Brest France Recruiting
Clermont-Ferrand University Hospital Clermont-Ferrand France Recruiting
Louis Mourier Hospital Colombes France Recruiting
Cèdres Clinic Cornebarrieu France Recruiting
Henri Mondor Hospital Créteil France Recruiting
Dax Hospital Dax France Withdrawn
Francois Mitterrand Hospital Dijon France Recruiting
Grenoble University Hospital Grenoble France Recruiting
Vendée Hospital La Roche-sur-Yon France Recruiting
La Rochelle Hospital La Rochelle France Recruiting
André Mignot Hospital Le Chesnay France Recruiting
Le Mans Hospital Le Mans France Recruiting
Lens Hospital Lens France Recruiting
Lille University Hospital Lille France Recruiting
Limoges University Hospital Limoges France Recruiting
Saint Joseph Saint Luc Hospital Lyon France Recruiting
La Timone Hospital Marseille France Recruiting
Mont de Marsan Hospital Mont-de-Marsan France Withdrawn
Moulins-Yzeure Hospital Moulins France Recruiting
Emile Muller Hospital Mulhouse France Recruiting
Nantes University Hospital Nantes France Recruiting
Nice University Hospital Nice France Recruiting
Orléans University Hospital Orléans France Recruiting
La Pitié Salpêtrière Hospital Paris France Recruiting
Pau Hospital Pau France Recruiting
Poitiers University Hospital Poitiers France Recruiting
Rennes University Hospital Rennes France Recruiting
Rouen University Hospital Rouen France Recruiting
Saint Nazaire Hospital Saint-Nazaire France Recruiting
Saintes Hospital Saintes France Recruiting
Foch Hospital Suresnes France Recruiting
Tours University Hospital Tours France Recruiting

+ 7 more sites — see the full list on the official registry below.

More Poitiers University Hospital trials in Spain

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05686850 on ClinicalTrials.gov ↗ ← All trials in Spain